Subscribe

Nada Elbuluk, MD, FAAD, discusses the clinical trial data behind ruxolitinib cream for vitiligo and its practical use in real-world dermatology. She explains how study outcomes have shaped treatment expectations and where this therapy fits within a modern, patient-centered vitiligo management toolkit.

Topics Covered:

• Key findings from ruxolitinib cream clinical trials
• Efficacy and safety considerations
• Patient selection and treatment expectations
• How ruxolitinib cream fits into current vitiligo treatment strategies
• Integrating new therapies into everyday dermatology practice

Explore Related Resources:

How to Use Ruxolitinib Cream for Vitiligo

Providing Adequate Treatment for Patients With Vitiligo